http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0311701-B8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
filingDate 2003-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1319b16858b8d28683a7bca4ff7aafab
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0311701-B8
titleOfInvention multiparticulate dosage pharmaceutical formulation coated with controlled release of lamotrigine
abstract "multiparticulate dosage formulation with controlled release of lamotrigine, pharmaceutical composition, process for the preparation of a pharmaceutical composition of lamotrigine, method for reducing peak fluctuation and deposition of drug concentration in a patient's blood plasma, method for improving a patient's compliance by reducing dosing frequency to once daily, method for safer administration of lamotrigine, method for providing a therapeutic blood plasma concentration of lamotrigine, and use of the formulation." The present invention relates to controlled release formulations of rapidly disintegrating multiple particles of lamotrigine having an improved pharmacokinetic profile and improved patient compliance and a process for preparing the formulations. the invention provides better control of blood plasma levels than conventional tablet formulations that are administered once a day.
priorityDate 2002-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507016

Total number of triples: 24.